Kadcyla 160mg injection is a specialized anti-cancer medication used primarily in the treatment of HER2-positive breast cancer. It contains ado-trastuzumab emtansine, a targeted therapy that combines a monoclonal antibody with a chemotherapy agent. Due to its advanced formulation and targeted action, Kadcyla is considered a high-cost medication worldwide, including in Pakistan. Understanding its price, availability, and factors influencing cost is essential for patients and caregivers managing cancer treatment.

Current Price of Kadcyla 160mg in Pakistan

The price of Kadcyla 160mg injection in Pakistan varies depending on the supplier, import status, and pharmacy. Based on available data, the cost typically ranges between PKR 138,000 and PKR 354,000 per vial.

Some online pharmacies list the price at approximately PKR 138,450, which is often considered a subsidized or regulated rate.
However, in other cases—especially when imported or sourced privately—the price can rise significantly, reaching around PKR 350,000 or more per vial.

This wide price variation highlights the importance of verifying the source and authenticity of the medication before purchase.

Why Is Kadcyla So Expensive?

Kadcyla is not a conventional chemotherapy drug. It is an antibody-drug conjugate (ADC), meaning it delivers chemotherapy directly to cancer cells while minimizing damage to healthy tissues. This advanced technology significantly increases production costs.

Additionally, Kadcyla is manufactured by a multinational pharmaceutical company and often imported into Pakistan. Import duties, currency fluctuations, and distribution costs further increase its retail price. The drug also requires strict cold-chain handling, which adds to logistics expenses.

Another factor is the lack of generic alternatives in many markets, which keeps prices high due to limited competition.

It works by targeting HER2 receptors on cancer cells and delivering a cytotoxic agent directly into them, slowing or stopping tumor growth.

Because of its targeted mechanism, Kadcyla is often used when other treatments such as trastuzumab or chemotherapy have not been fully effective.

Most pharmacies treat it as a special-order medicine, meaning patients may need to wait several days for delivery. Additionally, because it is a temperature-sensitive (cold chain) product, it cannot be handled like regular medicines.

Financial Burden on Patients

The high price of Kadcyla places a significant financial burden on patients in Pakistan. Since cancer treatment often requires multiple cycles, the total cost can quickly escalate into millions of rupees.

For example, if a patient requires multiple doses over several months, the cumulative expense can become unaffordable for many families. This is why some patients seek financial assistance through

Despite these efforts, access remains limited for many patients.

Conclusion

Nivolumab 100 mg injection price in pakistan is a life-saving but expensive cancer treatment option in Pakistan. With prices ranging from approximately PKR 138,000 to PKR 354,000 per vial, it remains one of the costliest oncology drugs available in the country. While its targeted mechanism offers significant therapeutic benefits, affordability and accessibility continue to be major challenges. Patients are advised to consult healthcare professionals and explore financial assistance options to manage the high cost of treatment effectively.